Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France

Press release – Inserm press room Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France Link : https://presse.inserm.fr/en/un-nouveau-traitement-entre-en-essai-clinique-chez-un-premier-enfant-achondroplase-en-france/42645/

Other contents In the same category :

Genetics, genomics and bioinformatics Voir tout

A Novel Genome Editing Tool for Rare Hereditary Diseases

Researchers from Inserm, Université d’Evry, Université Paris-Saclay and Genethon have developed a novel platform for modifying the genome of hematopoietic stem cells, which give rise to blood cells. The use of these tools could provide new therapeutic solutions for many patients with ...

Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France

Other contents In the same category :

A Novel Genome Editing Tool for Rare Hereditary Diseases

Launch of a European clinical trial against COVID-19

Les vaccins à ARNm susceptibles de modifier notre génome, vraiment ?

New Antibiotics Developed by Inserm and Université de Rennes 1

The BCG vaccine against COVID-19 – really?